BOTHELL, Wash.--(BUSINESS WIRE)--March 28, 2006--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that it intends to issue and sell 7,300,000 shares of common stock in an underwritten public offering pursuant to an effective registration statement. Banc of America Securities LLC and CIBC World Markets will act as joint book-running managers for the offering.
